A case of canine oral melanoma and treatment with the canine melanoma vaccine

Other Titles
Abstract
An eleven-year-old Labrador Retriever presented to Cornell University with oral melanoma, which is a highly malignant tumor. Conventional treatment (surgery, radiation, chemotherapy) has lead to overall median survival times of 6-12 months. New developments in immunotherapy, more specifically the recently licensed canine melanoma vaccine, offer new potential in the treatment of this aggressive cancer. The vaccine is a promising modality for melanoma therapy that can be used alone or preferably in combination with other conventional treatment modalities.
Journal / Series
Senior seminar paper
Seminar SF610.1 2008 N52
Volume & Issue
Description
Sponsorship
Date Issued
2007-09-12
Publisher
Keywords
Dogs -- Diseases -- Treatment -- Case studies
Location
Effective Date
Expiration Date
Sector
Employer
Union
Union Local
NAICS
Number of Workers
Committee Chair
Committee Co-Chair
Committee Member
Degree Discipline
Degree Name
Degree Level
Related Version
Related DOI
Related To
Related Part
Based on Related Item
Has Other Format(s)
Part of Related Item
Related To
Related Publication(s)
Link(s) to Related Publication(s)
References
Link(s) to Reference(s)
Previously Published As
Government Document
ISBN
ISMN
ISSN
Other Identifiers
Rights
Rights URI
Types
term paper
Accessibility Feature
Accessibility Hazard
Accessibility Summary
Link(s) to Catalog Record